Clinical Trial Update: A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) [Phase 2]

View source ↗

Summary

Phase II multi-histology trial evaluating FdCyd with THU in various cancers completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms
• Head and Neck Neoplasms
• Lung Neoplasms
• Urinary Bladder Neoplasms

Drugs mentioned

• FdCyd + THU (5-fluoro-2'-deoxycytidine with tetrahydrouridine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Head and Neck Neoplasms, Lung Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2019-12-27